Description
Empaglif-M 5/500 mg is a fixed-dose oral antidiabetic medication combining Empagliflozin, a selective SGLT2 inhibitor, and Metformin, a widely used biguanide. This dual-action formula helps improve glycemic control in adults with type 2 diabetes mellitus (T2DM) by both increasing urinary glucose excretion and decreasing hepatic glucose production.
 4ML.jpg)
.jpeg)
.webp)
 1000 MG.jpg)
.jpeg)
.webp)
.webp)
Change Language